'CELL-BASED ASSAY MARKET SET TO GROW TO $22BN BY 2022' SAYS VISIONGAIN REPORT

Visiongain’ has launched a new pharma report Cell-Based Assays World Industry and Market 2018-2028: Drug Discovery, Basic Research, Predictive Technology, Instrument, Consumables, Software, Services, Reagents, Assay Kits, Microplates, Cell Lines, Probes & Labels, Pharma & Biotech Companies, Academic Institutes, CROs.

Please click on this link for the TOC: https://www.visiongain.com/report/cell-based-assays-world-industry-and-market-2018-2028/

Cell-based assays hold a number of advantages over traditional biochemical assays and animal models, and these advantages have driven the increased demand for these assays in recent years. There has been an increased usage of cell-based assays as the preferred tool for screening potential drug compounds and toxicity screening, thus growing demand by drug development companies. The demand for cell-based assays will expand further due to increased allocation of resources towards drug discovery by companies, the presence of a large number of proteins which still have unknown functions, and the rising demand for biological drugs.

The lead analyst of the report commented “Whilst there are many factors driving growth in the cell-based assays market, market challenges still exist. Even though the cost of cell-based assays is gradually declining as the technology advances, the overall cost of cell-based assays and the equipment required to run them and analyse the data, is still high.

Please email sara.peerun@visiongain.com for a free report overview.

Another restraint is the complexity of cell-based assays, and the need for skilled individuals to run them and to analyse the data from them. The complexities of these assays also mean that the development of innovative new assays and products by cell-based assay companies is costly and can take a long time.”

Leading companies featured in the report include BD (Becton, Dickinson and Company), BioAgilytix Labs, BioVision, Cell Assay Innovations, Inc., Charles River Laboratories International, CYTOO SA, DiscoverX, GE Healthcare, InSphero,Marin Biological Laboratories, Molecular Devices, Perkin Elmer, Pharmaceutical Product Development, Porsolt, Promega, ProQinase GmbH, QGel, SGS Group, Inc., Thermo Fisher Scientific (and Affymetrix acquisition)

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 207 336 6100

Established in 1998, Visiongain is one of the fastest growing business intelligence providers helping you keep informed of key changes taking place in your industry. Based in London, UK, Visiongain publishes independent and insightful market reports produced by experienced analysts, many of whom are educated to masters and PhD level and are experts in their field. Visiongain also provides a bespoke reports service providing exclusive custom research tailored specifically for your individual needs.

Airport house, Purley way, CR0 0XZ, UK

This release was published on openPR.